Hydrochloric Acid

Hydrochloric Acid

SCHEMBL29660936

CC(N)CCc1ccccc1Cl.Cl

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 1/20 0.96
SLC6A4 known ✓ P31645 1/20 0.96
SLC6A3 known ✓ Q01959 1/20 0.96
KCNH2 known ✓ Q12809 1/20 0.46
HTR3E known ✓ A5X5Y0 1/20 0.44
HTR3B known ✓ O95264 1/20 0.44
HTR3A known ✓ P46098 1/20 0.44
HTR3D known ✓ Q70Z44 1/20 0.44
HTR3C known ✓ Q8WXA8 1/20 0.44
GLA known ✓ P06280 1/20 0.40
TAAR1 Q96RJ0 4/20 0.53
AOC3 Q16853 1/20 0.50
PNMT P11086 1/20 0.47
IDO1 P14902 4/20 0.46
LMNA P02545 3/20 0.40
DAO P14920 1/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30520623 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3TAAR1AOC3
SCHEMBL24182615 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3TAAR1AOC3
SCHEMBL268859 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3TAAR1AOC3
Bromide SCHEMBL14833289 0.85 SLC6A2 (0.77) SLC6A2SLC6A4SLC6A3TAAR1AOC3
SCHEMBL6680457 0.82 SLC6A2 (0.71) SLC6A2SLC6A4SLC6A3TAAR1AOC3
SCHEMBL16269085 0.82 SLC6A2 (0.71) SLC6A2SLC6A4SLC6A3TAAR1AOC3
SCHEMBL15271456 0.81 SLC6A2 (0.70) SLC6A2SLC6A4SLC6A3TAAR1AOC3
Hydrochloric Acid SCHEMBL3279906 0.80 SLC6A2 (0.63) SLC6A2SLC6A4SLC6A3TAAR1PNMT
Hydrochloric Acid SCHEMBL30559556 0.80 SLC6A2 (0.63) SLC6A2SLC6A4SLC6A3TAAR1PNMT
SCHEMBL10585872 0.78 SLC6A2 (0.67) SLC6A2SLC6A4SLC6A3TAAR1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250186369-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING, AMELIORATING, AND/OR PRVENTING COCAINE USE DISORDER UNIV DREXEL (US) 2025-06-12 US disclosed
CN-118791843-A Preparation method and application of modified polyester film 江阴纳力新材料科技有限公司 2024-10-18 CN disclosed
US-20240252553-A1 ENGINEERED S. TYPHIMURIUM AND USES THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2024-08-01 US disclosed
US-20240074993-A1 METHODS OF TREATING OR PREVENTING AN ATTENTION DISORDER, COGNITIVE DISORDER, AND/OR DEMENTIA ASSOCIATED WITH A NEURODEGENERATIVE DISORDER UNIV DREXEL (US) 2024-03-07 US disclosed
WO-2023172497-A2 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING COCAINE USE DISORDER DREXEL UNIVERSITY (US) 2023-09-14 WO disclosed
US-11744810-B2 Methods of treating or preventing an attention disorder, cognitive disorder, and/or dementia associated with a neurodegenerative disorder DREXEL UNIVERSITY (US) 2023-09-05 US disclosed
CN-114525964-B Conductive ratchet wheel assembly and preparation method thereof 张俊 2023-08-01 CN disclosed
CN-114525964-A Conductive ratchet wheel assembly and preparation method thereof 张俊 2022-05-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074993-A1 METHODS OF TREATING OR PREVENTING AN ATTENTION DISORDER, COGNITIVE DISORDER, AND/OR DEMENTIA ASSOCIATED WITH A NEURODEGENERATIVE DISORDER CHAT, COMT, SLC6A2 SLC6A2 3/4885SLC6A4 15/4885SLC6A3 5/4885
US-20250186369-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING, AMELIORATING, AND/OR PRVENTING COCAINE USE DISORDER CES2, CHAT, SLC18A2 SLC6A2 7/4885SLC6A4 33/4885SLC6A3 4/4885
US-11744810-B2 Methods of treating or preventing an attention disorder, cognitive disorder, and/or dementia associated with a neurodegenerative disorder CHAT, COMT, SLC6A2 SLC6A2 3/4885SLC6A4 15/4885SLC6A3 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.